1. Protective efficacy of intravenous Zanamivir in experimental human influenza. Abstract H58 presented at the 38th Interscience Conference of Antimicrobial Agents and Chemotherapy held on 24-27 September 1998;Calfee
2. Protective efficacy of reduced frequency dosing of intranasal Zanamivir in experimental human influenza. Abstract H68 presented at the 38th Interscience Conference of Antimicrobial Agents and Chemotherapy held on 24-27 September 1998;Calfee
3. Efficacy of intranasal GG167 in experimental human influenza A and B virus infection. In Brown LE, Hampson AW, Webster RG. Options for the control of influenza III;Hayden
4. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza;Hayden;Journal of the American Medical Association,1996
5. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza;Hayden;Journal of the American Medical Association,1996